HomeCompareDCHPF vs PLD

DCHPF vs PLD: Dividend Comparison 2026

DCHPF yields 1.17% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DCHPF wins by $1.38M in total portfolio value· pulled ahead in Year 10
10 years
DCHPF
DCHPF
● Live price
1.17%
Share price
$46.90
Annual div
$0.55
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.89M
Annual income
$6,778,497.55
Full DCHPF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — DCHPF vs PLD

📍 DCHPF pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDCHPFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DCHPF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DCHPF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DCHPF
Annual income on $10K today (after 15% tax)
$99.68/yr
After 10yr DRIP, annual income (after tax)
$5,761,722.92/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, DCHPF beats the other by $1,293,752.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DCHPF + PLD for your $10,000?

DCHPF: 50%PLD: 50%
100% PLD50/50100% DCHPF
Portfolio after 10yr
$7.20M
Annual income
$6,017,466.87/yr
Blended yield
83.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

DCHPF
No analyst data
Altman Z
4.3
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DCHPF buys
0
PLD buys
0
No recent congressional trades found for DCHPF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDCHPFPLD
Forward yield1.17%3.18%
Annual dividend / share$0.55$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%74.4%
Portfolio after 10y$7.89M$6.50M
Annual income after 10y$6,778,497.55$5,256,436.18
Total dividends collected$7.78M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DCHPF vs PLD ($10,000, DRIP)

YearDCHPF PortfolioDCHPF Income/yrPLD PortfolioPLD Income/yrGap
1$10,935$234.54$11,255$555.24$320.00PLD
2$12,179$479.37$13,062$1,018.59$883.00PLD
3$14,030$998.01$15,903$1,926.67$1.9KPLD
4$17,161$2,148.88$20,839$3,823.32$3.7KPLD
5$23,275$4,912.97$30,464$8,166.08$7.2KPLD
6$37,359$12,454.96$52,054$19,457.30$14.7KPLD
7$77,342$37,367.67$109,886$54,188.93$32.5KPLD
8$227,353$144,597.06$304,030$186,451.18$76.7KPLD
9$1,037,762$794,493.85$1,166,125$840,813.32$128.4KPLD
10← crossover$7,888,903$6,778,497.55$6,504,190$5,256,436.18+$1.38MDCHPF

DCHPF vs PLD: Complete Analysis 2026

DCHPFStock

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Full DCHPF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this DCHPF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DCHPF vs SCHDDCHPF vs JEPIDCHPF vs ODCHPF vs KODCHPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.